L-glutamine low dose
Selected indexed studies
- A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. (N Engl J Med, 2018) [PMID:30021096]
- Nutrition in Sepsis: A Bench-to-Bedside Review. (Nutrients, 2020) [PMID:32024268]
- Nutritional interventions for treating foot ulcers in people with diabetes. (Cochrane Database Syst Rev, 2020) [PMID:32677037]
_Worker-drafted node — pending editorial review._
Connections
L-glutamine low dose helps
Sources
- A Phase 3 Trial of l-Glutamine in Sickle Cell Disease. (2018) pubmed
- Nutritional interventions for treating foot ulcers in people with diabetes. (2020) pubmed
- Nutrition in Sepsis: A Bench-to-Bedside Review. (2020) pubmed
- Low-dose exposure to phytosynthesized gold nanoparticles combined with glutamine deprivation enhances cell death in the cancer cell line HeLa via oxidative stress-mediated mitochondrial dysfunction and G0/G1 cell cycle arrest. (2022) pubmed
- Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome. (2019) pubmed
- Oral low dose of glutamine improved the spontaneous closure in patients with external duodenal fistula: a retrospective comparative study with propensity score matching. (2025) pubmed
- PMID:29381293 (2017) pubmed
- A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines. (2015) pubmed
- No protective benefits of low dose acute L-glutamine supplementation on small intestinal permeability, epithelial injury and bacterial translocation biomarkers in response to subclinical exertional-heat stress: A randomized cross-over trial. (2022) pubmed
- Gastrointestinal Tolerance of Low, Medium and High Dose Acute Oral l-Glutamine Supplementation in Healthy Adults: A Pilot Study. (2020) pubmed